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Metabolic Syndrome (MetS) is classified by a group of risk factors including 
impaired blood glucose levels, hypertension, obesity, and dyslipidemia, which is often 
accompanied with increased inflammation and oxidative stress [1, 2].  According to the 
2003-2006 National Health and Nutrition Examination Survey (NHANES), nearly 47 
million US adults, 35% of men and 32% of women, have Metabolic Syndrome or the 
beginnings of the condition.  Risk is significantly higher with age and increased body 
mass index (BMI) [1-3].  Research has shown that diets rich in antioxidants, specifically 
the flavonoid rich foods, can lower some biomarkers of oxidative stress and 
inflammation.   
Atherosclerosis and, therefore the expression and adhesion of these molecules, are 
stimulated by several factors including “consuming a high-saturated-fat diet, smoking, 
hypertension, hyperglycemia, obesity, or insulin resistance”, many of which are t e same 
criteria for metabolic syndrome [4].  Many studies have shown a strong connecti  
2 
 
between a diet rich in saturated fatty acids, low in monounsaturated and polyunsaturated 
fatty acids, and the biomarkers of inflammation.  The biomarkers of inflammation of 
interest include C-Reactive Protein (CRP), Interleukin-6, and the anti-inflammatory 
marker, adiponectin [5, 6].  Obesity greatly increases CRP levels and by losing weight, 
inflammation is reduced significantly, thus decreasing risk of CVD and Metabolic 
syndrome [5]. 
Diets rich in antioxidants, specifically flavonoids, can lower some biomarkers of 
oxidative stress and inflammation.  Antioxidants are essentially a defense mechanism 
against free radicals and reactive oxygen species (ROS) which are responsible for the 
oxidative stress and damage in many disease states, including Metabolic Syndrome and 
cardiovascular disease (CVD).  Some of the endogenous antioxidant systems include the 
superoxide dismutase (SOD) and glutathione (GSH) system while exogenous 
antioxidants are Vitamins C and E, flavonoids, and carotenoids [7].  They are pertinent to 
scavenging free radicals and keeping a balance in the body so oxidative stress does not 
occur, exacerbating disease states [7].  Flavonoids are plant-derived polyphenols t at 
provide several positive health benefits including antiviral, antineoplasic, hypolipidemic, 
and anti-inflammatory activities [8].  All of these characteristics are important but the 
anti-inflammatory properties are crucial in the reduction of inflammation and oxidative 
stress in atheroslcerosis and metabolic syndrome.  Flavonoids reduce the risk and 
biomarkers of inflammation and oxidative stress but few studies have shown how 
blueberry flavonoids affect the biomarkers of oxidative stress and metabolic syndrome.  
Therefore, more research is needed in this area of antioxidant and nutrition knowledge. 
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The objective of our study was to investigate the antioxidant effects of blueberry 
flavonoids on inflammation and antioxidant status in subjects identified with Metabolic 
Syndrome.  Furthermore, we intended to identify foods consumed in the Central 
Oklahoma area that are rich in antioxidants and quantify the intake of these foods. 
 
Study hypotheses: 
1. Blueberry supplementation will have no effect on the biomarkers of 
inflammation. 








Obesity and Inflammation 
Obesity is an epidemic becoming more prominent in the American society, with 
32.2% of adult men and 35.5% adult women being obese according to the 2007-2008 
NHANES [9].  Obesity is an unnatural state for the body, being defined as a body mass 
index (BMI) being greater than 30 kg/m2 and is often accompanied with a chronic low-
grade inflammatory state[10, 11].  This inflammation is characterized with increased 
levels of the acute phase protein, C-reactive protein (CRP) and the cytokine, interl ukin-6 
(IL-6) [10, 11].  IL-6 is a known marker of inflammation due it being an adipose-tissue 
produced cytokine highly associated with obesity, type 2 diabetes, and cardiovascular 
disease [12, 13].  Studies have shown that obese individuals have increased IL-6 serum 
levels and may also be related to insulin resistance.  It has also been shown that IL-6 is 
responsible for down-regulating adiponectin levels and stimulates CRP production in the 
liver, which further attenuates the obese state [11, 13, 14].  In addition, the Physicians’ 
Health Study (PHS) has shown that IL-6 is a predictor of cardiovascular risks, including 
atherosclerosis, myocardial infarction, peripheral vascular disease, and death [14].  This 
study was completed with healthy men and suggested that IL-6 levels in the highest 
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quartile were more at risk than the lowest quartile of experiencing a cardiov scular event 
[14].  Furthermore, C-reactive protein has been intensively studied and results show that 
the level of adiposity in the body correlates to the elevated level of CRP [10]. 
Metabolic Syndrome and Inflammation 
Metabolic Syndrome (MetS) is classified by a group of risk factors including 
impaired blood glucose levels, hypertension, abdominal adiposity, and dyslipidemia, that 
is often accompanied with increased inflammation, oxidative stress, and prothrombotic 
condition [1-3, 15-19].  Furthermore, insulin resistance and central obesity are commonly 
associated with the metabolic syndrome [15, 19].  Alberti et al states that individuals who 
have metabolic syndrome are more likely to develop cardiovascular disease and 
complications in five to ten years compared to healthy individuals.  In addition, those 
with metabolic syndrome have about a 5-fold risk increase in developing type 2 diabetes 
[15].  Qualifying criteria for the metabolic syndrome are defined in Table 1 according to 
the National Cholesterol Education Program Adult Treatment Panel (ATP III) in the 
United States [15, 17]. 
Table 1. Metabolic Syndrome Qualifying Criteria [15, 17] 
Measure Clinical Values 
Elevated waist circumference Men: ≥102 cm; Women: ≥88 cm 
Elevated triglycerides ≥150 mg/dL 
Reduced HDL-C Men: <40 mg/dL; Women:<50 mg/dL 
Elevated blood pressure Systolic ≥130 and/or diastolic ≥ 85 mm 
Hg 
Elevated fasting glucose ≥100 mg/dL 
 
According to the 2003-2006 National Health and Nutrition Examination Survey 
(NHANES), about 47 million US adults, 35% of men and 32% of women, have 
Metabolic Syndrome or the beginnings of the condition  Risk is significantly higher with 
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age and increased body mass index (BMI) [1-3].  These values are significantly 
increasing every year with more American adults being affected with a disease that could 
possibly treated, if not prevented, with nutrition therapy and health diets. 
A pro-inflammatory state, as seen in metabolic syndrome and cardiovascular 
disease, encourages the initiation of atherosclerosis by promoting the adhesion of 
leukocytes and monocytes to the endothelial surface in the vascular system [4].  These 
adhesion molecules, including VCAM and ICAM, initiate a vicious cycle in which the 
recruitment of more molecules potentiates the inflammation.   The progression of the 
disease occurs when the monocytes migrate to the intima of the artery and conti ue to 
change when they engulf oxidized LDL molecules, forming foam cells [4].  With all of 
these pro-inflammatory changes, a fatty plaque and eventually a fragile fibrous cap are 
formed.  Over time, the fibrous cap weakens by irritation from the inflammatory 
compounds, which can lead to thrombosis and other fatal complications [4].  
Atherosclerosis and the expression and adhesion of these molecules, are stimulated by 
several factors including hypertension, consuming a high fat diet, specifically saturated 
fat, smoking, hyperglycemia, obesity, and insulin resistance, with the latter thre  
belonging to the criteria for metabolic syndrome [4].   
Many studies have shown a strong connection between a diet rich in saturated 
fatty acids, low in monounsaturated and polyunsaturated fatty acids, and the biomarkers 
of inflammation.  These biomarkers of inflammation include C-reactive protein (CRP), 
IL-6, and adiponectin [4, 6, 11].  C-reactive protein is an acute phase reactant and another 
marker of inflammation that has been determined a predictor of cardiovascular events 
including myocardial infarction, stroke, peripheral vascular disease, coronary heart 
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disease, and cardiovascular death [14, 20].  More specifically associated with metabolic 
syndrome, CRP is linked with increased triglyceride levels, high blood pressure, elevated 
fasting glucose and insulin resistance, endothelial dysfunction, and obesity [21].  It is 
commonly produced in the liver and production is stimulated by cytokines IL-6 and IL-
1β, but is also produced by smooth muscle cells in the coronary arteries and macrophages 
through extra-hepatic mechanisms [14, 20, 21].  CRP is an integral part of atherogenesis 
and the production of plaque in atherosclerosis [14, 20].  Furthermore, it seems to be 
thoroughly involved in the expression of the cell adhesion molecules, ICAM-1 and 
VCAM-1, mediates the induction of monocyte chemoattractant protein-1 (MCP-1) and 
the uptake of LDL by the macrophages.  Research also shows that CRP has the capability 
to activate the immune response complement and when they are bound together, the 
mRNA from both components is significantly up-regulated in the plaque produced in 
atherosclerosis [14].  In addition, studies have shown the combined effects of CRP and 
LDL cholesterol, indicating that when they act together, the risk of a cardiovascular event 
is significantly increased [21].  For instance, in the Women’s Health Study, women with 
severely elevated levels of both LDL and CRP were at greater risk of a cardiovascular 
event leading to death compared to those with low levels of both.  Furthermore, when 
CRP levels were elevated and LDL were low, the women were at a greater risk of death 
compared to those with lower CRP levels and increased LDL cholesterol [21]. 
Obesity, specifically central adiposity as seen in metabolic syndrome, greatly 
increases CRP levels.  When associated with dyslipidemia, another aspect of m tabolic 
syndrome, CRP levels increase significantly [20].  The Women’s Health Study pro uced 
results that indicated that elevated CRP levels in women were a strong predictor for 
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developing diabetes.  Furthermore, this same study conducted with non-diabetic women 
suggested that slightly elevated CRP levels correlated with insulin resistance, linking the 
development of diabetes, cardiovascular disease, and metabolic syndrome with low-grade 
inflammation [20].  Research suggests with weight loss, inflammation is reduced 
significantly, thus decreasing risk of cardiovascular disease and metabolic syndrome [5]. 
Adiponectin is an important anti-atherosclerotic adipose tissue-specific protein 
that is typically found in circulation in humans [12].  Research has shown that circulating 
adiponectin helps increase the occurrence of weight loss and improve insulin resistanc , 
while decreasing the occurrence of dyslipidemia, diabetes, and cardiovascular disease, all 
of which are components of metabolic syndrome.  In subjects with metabolic syndrome, 
circulating adiponectin is low and is linked with diabetes and insulin resistance [22].  
Furthermore, cytokines, including IL-6, regulate adiponectin and have been shown to 
inhibit its activity [12].   
Antioxidant Systems 
Antioxidants are defense mechanisms against free radicals and reactive oxygen 
species (ROS) which are responsible for the oxidative stress and damage in many dise se 
states, including metabolic syndrome and cardiovascular disease.  Some of the 
endogenous antioxidant systems include the superoxide dismutase (SOD), glutathione 
(GSH) system, and catalase (CAT) while exogenous antioxidants are Vitamins C and E, 
flavonoids, and carotenoids [8].  They are pertinent to scavenging free radicals nd 
keeping a balance in the body so oxidative stress does not occur [8].  Flavonoids are 
plant-derived polyphenols that provide several positive health benefits including antiviral, 
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antineoplasic, hypolipidemic, and anti-inflammatory activities [23].  All of these 
characteristics are important but the anti-inflammatory properties are crucial in the 
reduction of inflammation and oxidative stress in atheroslcerosis and metabolic 
syndrome.  The flavonoids in tea and soy are potent antioxidants in reducing the 
biomarkers of free radicals in oxidative stress and inflammation [24].  A three we k 
intervention with fruit juice rich in anthocyanins and polyphenols showed that DNA 
oxidative damage, lipid peroxidation, and oxidative damage decreased while glutathione 
and endogenous antioxidant status was increased significantly [25].  In vivo studies have 
presented that the flavonoids in citrus fruits, flavanones, promote the antioxidant 
properties of reducing oxidative damage [25].  Flavonoids reduce the risk and biomarkers 
of inflammation and oxidative stress but few studies have shown how blueberry 
flavonoids affect the biomarkers of oxidative stress and metabolic syndrome.  Therefore, 
more research is needed in this area of antioxidant and nutrition knowledge. 
The catalase system is an endogenous antioxidant system, most active in the 
peroxisome of the cells of the liver, kidney, and erythrocytes, responsible for converting 
harmful reactive oxygen species to less toxic products in the body [26, 27].  The primary 
substrate for the catalase enzyme is hydrogen peroxide, which binds to the enzyme, 
forming an intermediate complex.  This complex binds another hydrogen peroxide 
molecule, producing two molecules of water and one molecule of oxygen [27].  The 
catalase-hydrogen peroxide intermediate complex can also bind with hydrogen d nors, 




 Carotenoids, specifically α-carotene, β-carotene, lutein, and lycopene, are another 
antioxidant source that assists in scavenging the free radicals often seen iinflammation, 
oxidative stress, and thus Metabolic Syndrome [19].  It has been determined that 
carotenoids, specifically β-carotene and lycopene, help guard against damaging oxidation 
in cells as well as reducing the risk of hypertension [28].  Poudyal et al observed that 
carotenoids and anthocyanins from purple carrot juice reversed the effects of a high-f t, 
high-carbohydrate diet in rats, undoing the harmful damage seen in metabolic syndrome 
[28].  Czernichow et al demonstrated that subjects with metabolic syndrome 
supplemented with β-carotene and Vitamin C, had a decreased risk of the condition 
worsening [19].  Sugiura et al observed that in smokers at risk of developing metabolic 
syndrome due to the oxidative stress from the smoking, serum levels of α-carotene and β-
carotene were inversely related [29].  Sluijs et al investigated dietary carotenoid levels in 
men with metabolic syndrome and observed that dietary carotenoids, specifically β-
carotene and lycopene, were associated with lower incidence of metabolic syndrome.  
Furthermore, higher total carotenoid intakes were related to lower adiposity, waist 
circumference, and serum triglyceride levels [30].  Coyne et al investigated that serum 
carotenoids, particularly α-carotene, β-carotene, lutein, and lycopene, improve impaired 
glucose tolerance and type 2 diabetes, two criteria in the metabolic syndrome [31].  In 
another clinical study by Coyne et al, it was observed that the development of metabolic 
syndrome in adults who consumed fewer servings of fruits and vegetables was higher; 
furthermore, they noticed that these individuals had lower serum carotenoid levels as well 





Diets rich in dietary polyphenols and antioxidants, specifically flavonoids, can 
lower some biomarkers of oxidative stress and improve antioxidant status.  These diets 
tend to include several servings of fruits and vegetables which contain many of these 
powerful compounds [33].  Polyphenols are most commonly found in plants and have 
diverse functions based on their chemical structures.  Specifically, dietary polyphenols 
are known as reducing agents and play the biggest role in protecting against oxidative 
stress in the body.  There are several subclasses of dietary polyphenols which are 
determined by their structure; these include phenolic acids, flavonoids, stilbenes, and 
lignans [34].  Phenolic acids are found in a myriad of foods including wheat bran, coffee, 
and many berries.  Flavonoids are another common polyphenol and are the most 
abundant dietary antioxidants.  Common flavonoids, subclasses, and dietary sources are 
listed in Table 2 [23]. 
Table 2. Flavonoid Subclasses [23] 
Flavonoid Subclasses Compounds Dietary Sources 
Flavonols Quercetin, Kaempferol, 
Myricetin 
Onions, Broccoli, Tea, 
Fruits 
Flavones Apigenin, Luteolin Parsley, Celery, Tea 
Flavanones Naringenin, Hesperetin Citrus Fruits 
Flavan-3-ols Catechin, Epicatechin Cocoa, Apples, Grapes, 
Red Wine, Green Tea, 
Black Tea 









Burns Kraft et al observed that the polyphenols, specifically anthocyanins and 
proanthocyanidins, in wild berries are responsible for decreasing inflammation, reducing 
insulin resistance, and improving the overall health of individuals with metabolic 
syndrome [35].  Basu et al, demonstrated that a 4-week intervention of freeze-dried 
strawberry supplementation in women with metabolic syndrome had a positive effect of 
lowering total cholesterol, LDL-cholesterol levels, and lipid peroxidation [36].  
Furthermore, in a different study conducted by Basu et al, they observed that short-term 
strawberry supplementation decreased inflammation biomarkers, improved dyslipidemia 
in individuals with metabolic syndrome, but had no effect on other metabolic syndrome 
criteria including blood pressure, glucose levels, adiposity, or cholesterol levels [37].  
Jensen et al demonstrated that consumption of a juice blend containing nearly 20 fruits 
and berries, including blueberries, in healthy adults, improved serum antioxidant capaci y 
less than 2 hours post prandial [38].  Therefore, the researchers indicated that the active 
antioxidants in fruits have a potential effect of improving antioxidant status and lowering 
biomarkers of inflammation and dyslipidemia [38]. 
Polyphenol Intake 
According to the Center for Disease Control (CDC) in 2007, 4.5% of people in 
Oklahoma consumed fruits and vegetables never or less than one time per day.  
Furthermore, 40.6% of individuals consumed fruits and vegetables 1-2 times per day, 
37.7% ate them 3-4 times per day, and only 17.2% consumed them 5 or more times per 
day [39].  According to the 2009 State Indicator Report on Fruits & Vegetables published 
by the CDC, less than 10% of adults aged 18 years and older in Oklahoma consumed 
fruit more than two times per day and vegetables more than three times per day [40]. 
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Polyphenols, specifically those in fruits and vegetables, are important in 
preventing many disease states, such as cardiovascular disease and cancer, because the 
foods that contain them have less saturated fat and cholesterol than are found in animal 
products [41].  A study completed in France to determine daily intake of polyphenol 
compounds, specifically those in fruits and vegetables, showed that these sources 
provided nearly 47% of the total polyphenol intake daily in this diet [41].  Tamers et al 
observed that the French consumed more fruits and vegetables more often compared to 
Americans and showed an inverse relationship between BMI and servings consumed per 
day [42].  Guenther et al observed that between 1999-2000, only about 40% of the U.S. 
population consumed the recommended five or more servings per day of fruits and 
vegetables, indicating that less than half of the population was getting the health benefits 
from these food groups [43].  Furthermore, according to the CDC September 2010 
Morbidity and Mortality Weekly Report, the percentage of 18 year olds and older 
consuming fruits and vegetables decreased by 4% for both food groups between 2000 and 
2009 [44]. 
Blueberry Polyphenols 
Blueberries have high levels of polyphenols that have antiglycemic, anti-obesity, 
and hypotensive benefits [45].  Blueberries are nutrient rich containing folic acid, 
selenium, and calcium, as well as several crucial antioxidants such as Vitamins C and E, 
lutein, carotenoids [45, 46].  In the United States, blueberry varieties have an oxyge 
radical absorbance capacity (ORAC) value of about 14-45.9 µmol/g, with a higher ORAC 
value indicating a higher efficiency of neutralizing free radicals [47, 48].  The following 
table illustrates the specific nutrients and polyphenols in a 100 gram edible portion. 
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Table 3. Nutrient and polyphenol amounts in a 100 g edible portion of blueberries 
[46] 
Nutrient Amount  
Calories 57 
Fiber (g) 2.4 
Vitamin C (mg) 9.7 
Vitamin E (mg) 0.57 
Total anthocyanidins (mg)* 163.52 
Total flavan-3-ols (mg)¥ 51.71 
Total flavonols (mg)1 9.72 
*Total anthocyanidins (cyanidin, delphinidin, peonidin, petunidin) 
¥Total flavan-3-ols [(-)-epicatechin, (-)-epicatechin 3-gallate, (-)-epigallocatechin,  
(-)-epigallocatechin 3 gallate, (+)-catechin, (+)-gallocatechin] 
1Total flavonols (kaempferol, myricetin, quercetin) 
 
The most prominent flavonoids in blueberries are the anthocyanins, which are most 
concentrated in the skin of the berry, giving the deep, vibrant colors [49].  Furthermore, 
the content is closely related to the intensity of the color and tends to increase with 
ripening.  Not only do blueberry anthocyanins have antioxidant properties, they also are 
anticarcinogenic, neuroprotective, cardioprotective, and protect the integrity of DNA 
[49].  Furthermore, anthocyanins have been shown to specifically reduce hypertension, 
dyslipidemia, and glucose intolerance in metabolic syndrome [28].  On a negative note, 
anthocyanins are not very bioavailable and are typically excreted in 2-8 hours t rough the 
urine [46, 49].   
Recently, Wu et al observed that dietary blueberry supplementation in 
Apolipoprotein E-deficient mice reduced oxidative stress by decreasing the level of lipid 
peroxidation and boosts endogenous antioxidant systems, specifically SOD and GSR 
[50].  Another recent study by Takikawa et al found that blueberry supplementation in 
type 2 diabetic KK-Ay mice decreased blood glucose levels and allowing for increased 
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insulin sensitivity [51].  Tsada observed in mice that anthocyanins, specifically those
found in blueberries, prevented obesity caused by a high-fat diet and also reduced other 
criteria seen in metabolic syndrome [52].  
 There are very few clinical studies showing the effects of blueberry 
supplementation but the studies available illustrate positive benefits.  Erlund et al 
observed that berry consumption, including blueberries, significantly decreased systolic 
blood pressure and significantly increased serum HDL cholesterol in the berry group 
compared to the control group; furthermore, plasma polyphenol and Vitamin C levels 
increased in the berry intervention group [53].  Basu et al observed that freeze-dried 
blueberry supplementation significantly decreased blood pressure and biomarkers of 
inflammation in individuals with metabolic syndrome [54].  Stull et al demonstrated that 
blueberry supplementation in obese, non-diabetic, insulin resistant individuals great y
improved insulin sensitivity, but had no effect on the inflammatory markers or the obesity 
[55].  Qin et al observed that blueberry anthocyanins decreased LDL-cholesterol and 
increased HDL-cholesterol in adults with dyslipidemia [56].  Mazzo et al found that 
blueberry supplementation in men slightly increased plasma antioxidant capacity for a 
limited period of time.  However, the authors mention that this slight increase cannot be 
directly associated with a reduction in the parameters for cardiovascular dise se or 
chronic disease [57].  McAnulty et al observed that daily consumption of 250 grams of 
blueberries in smokers for three weeks reduced levels of lipid hydroperoxides but had no 
effect on blood pressure or plasma antioxidant capacity [58] .  The researchers speculate 
that with this slight reduction in lipid hydroperoxides, blueberries moderately consumed 
on a regular basis could potentially lower the risk of developing cardiovascular dise se 
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[58].  In addition, Kay et al observed that supplementation of freeze-dried blueberries 
improved serum antioxidant status in healthy adult males after consuming a high-fat diet 
[59].  However, the authors mentioned that although the blueberries did have a positive 
effect on the parameters of cardiovascular disease, the study did not measure the exact 
compound in the blueberries to which these changes could be attributed [59]. 
Pedersen et al observed that consumption of blueberry juice in healthy female 
participants had no effect on plasma antioxidant capacity; however, consumption of 500 
milliliters of cranberry juice in healthy females did increase plasma antioxidant capacity.  
The researchers speculate that the antioxidants in the blueberries were not as bioav ilable 
as those in the cranberry juice [60].  Bub et al observed no difference in overnight plasma 
antioxidant status after a 2 week juice supplementation in healthy adult men, while it did 
improve total antioxidant status and slightly decreased oxidative stress [61].  Van der 
Berg et al noticed that a high fruit and vegetable intake in male smokers increased serum 
antioxidant status but not enough to reduce the oxidative stress biomarkers to a level that 
would lower the risk of developing chronic disease.  The researchers suggest that the fruit 
and vegetable intakes for this study were still too low to show significant changes in 








This study aimed to investigate the effects of blueberry flavonoid supplementation 
on the biomarkers of inflammation and antioxidant status in subjects with metabolic 
syndrome.  Subjects with metabolic syndrome were recruited for the study at Oklahoma 
State University and the University of Oklahoma Health Sciences Center.  All subjects 
were consented and entered into the study following the approval of the IRB at Oklahoma 
State University and the corresponding human ethics committees at Oklahoma Health 
Sciences Center.  Nineteen subjects in the blueberry intervention group had complete 






19 subjects identified with Metabolic 
Syndrome (MeS) 
↓ 
Freeze-dried whole blueberry drink 
(50g/day) 
↓ 
8 week intervention period (from 
baseline) 
↓ 
Subjects visit GCRC 3 days/week to 
consume the blueberry drink to 
ensure compliance 
↓ 
Blood draws and anthropometrics at 
screen and 8 weeks 
↓ 
3-day food records kept for screen and 









8 week intervention period (from 
baseline) 
↓ 
Subjects visit GCRC 3 days/week to 
consume drink to ensure compliance 
↓ 
Blood draws and anthropometrics at 
screen and 8 weeks 
↓ 
3-day food records kept for screen and 





Inclusion criteria : according to the NCEP guidelines, the subject should possess any 
three of the following features to fall in the category of Metabolic Syndrome: Waist 
circumference (≥102 cm in men & ≥88 cm in women), triglycerides ≥150 mg/dL, HDL 
(<40 mg/dL in men & <50 mg/dL in women), blood pressure ≥ 130/85 mm Hg, fasting 
glucose (≥100 mg/dL).  Adult subjects with normal Hb, WBC, platelets, liver, renal, and 
thyroid tests were included in the study.  Subjects on stable medications throughout the 
study were included. 
Exclusion criteria: any form of pre-existing disease, e.g. cancer, heart disease, diabetes 
(fasting glucose ≥126 mg/dL), liver or renal disorders, anemia, pregnancy and lactation, 
women on hormone replacement therapy, taking mega doses of antioxidants or fish oil 
supplements, abnormal Hb (normal range: 12.0 – 18.0 g/dL), WBC (normal range: 4.0 – 
11.0 K/mm3), hypo/hyperthyroidism (normal range for thyroid stimulating hormone: 0.35 
– 4.940 uiu/mL), abnormal liver enzymes (normal range for AST: 7 – 40 units/L; ALT: 
10 – 45 units/L), abnormal kidney function (normal creatinine: females: 0.7 – 1.2 mg/dL; 
males: 0.8 – 1.2 mg/dL; normal BUN: 1 – 59 years: 7 – 18 mg/dL; >59 years: 8 – 21 
mg/dL), smoking, and drinking alcohol (>1 oz/day) were excluded from the study.   
Any subject with deviations from the normal range of Hb, WBC, platelets, liver enzymes, 
BUN, creatinine, or TSH during the study period, were discontinued from the study.  
Both males and females, as well as individuals from any ethnic group, who qualified, 
were included in the study.  Women were included in the study, and blood draws and 
anthropometric measurements were conducted between days 6 – 15 of their menstrual 
cycle to control for the influence of hormone on the variables of interest.  Children wer  
not included in the study because the mechanisms underlying the Metabolic Syndrome in 
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children are different from those in adults, and also the effects of chronic consumption of 
freeze-dried whole blueberry drink is not supported by research in children.  Fasting 
blood draws, by a certified phlebotomist, were taken at screening, 4, and 8 weeks of the 
study to determine liver, renal, thyroid function tests, glucose, lipid levels, and 
biomarkers of oxidative stress and inflammation.  Anthropometrics were also perform d 
at these time points to measure height, weight, and body fat percentage.  Subjects wer  
asked to maintain 3-day food records during the 8-week study period.  All subjects were 
recruited at the OUHSC campus and OSU campus. 
Clinical analyses 
Blood samples were collected immediately after each draw and transported to th  
University of Oklahoma Medical Center (OUMC) Laboratory for analyses of fasting 
glucose, insulin, lipid profile [total cholesterol, triglycerides, low-density lipoproteins 
(LDL), high-density lipoproteins (HDL)], and other blood variables including safety 
parameters [hemoglobin (Hb), platelets, white blood cells (WBC), liver enzymes, 
creatinine, body urea nitrogen (BUN), electrolytes, albumin, total protein, and thyroid-
stimulating hormone (TSH)].  HbA1C was analyzed using a DCA 2000+ (Bayer 
Corporation, Elkhart, IN).  Insulin resistance was evaluated by homeostasis model 
assessment (HOMAIR) calculated as [fasting insulin (µU/mL) x fasting glucose 
(mmol/L)]/22.5. 
For assays to determine adiponectin, interleukin-6 (IL-6), and high sensitivity C-reactive 
protein (hs-CRP), serum and EDTA-plasma samples were collected1, separated by 
centrifugation (3000 rpm for 10 min at 4° C) and stored at 80°C for subsequent analyses.  
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ELISA procedures were performed to analyze the levels of biomarkers of inflammation.  
The endogenous antioxidant status was determined using the Catalase assay.  Dietar  
flavonoid intake and status was determined by analyzing the 3-day food records from 
screen and week 8. 
Biomarkers of inflammation 
Plasma concentrations of CRP, adiponectin, and IL-6 were determined using ELISA kits 
(R&D Systems, Inc. Minneapolis, MN) according to the manufacturer’s protocols.  The 
plasma was diluted in diluents buffer in the following ratios: 1/10000, 1/10000, 1/1, 
1/1000, and 1/1000, respectively.  The minimum detectable levels were 15.6, 62.5, 9.4, 
15.6, and 15.6 pg/mL for each assay, respectively.  The inner assay CVs were 6.2, 3.6, 
3.1, 3.5, and 7.6%, respectively. 
Serum Carotenoid analyses 
Serum carotenoids were measured by high performance liquid chromatography (HPLC) 
using a slightly modified combined version of the procedures previously described by 
Lee et al. [62] and Karppi et al. [63].  HPLC-grade standards and reagents were 
purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).  Briefly, 200 µl serum sample 
was deproteinized with 200 µl ethanol-butylated hydroxytoluene (BHT) containing 50 µl 
internal standard cocktail, vortexed, and extracted with 1000 µl n-hexane for 60 seconds, 
dried under a stream of nitrogen for 10 minutes, and finally reconstituted in 200 µl
ethanol-BHT solution.  Fifty µl was then injected onto a 4.6 mm C-18 Ultrasphere ODS 
HPLC column (Beckman, MA), and eluted with an isocratic solvent consisting of 
methanol (60%), acetonitrile (20%), and dichloromethane (20%) at a flow rate of 0.8 
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ml/minute.  The HPLC system included the 515 pump, the 2996 photodiode array 
detector, and the Rheodyne 7725i manual injector (Waters, Milford, MA, USA).  The 
carotenoids (α-carotene, β-carotene, lycopene, and lutein) and β-Apo-8’-carotenal 
(internal standard III) were detected at 450 nm using Waters PDA detection system.  Data 
acquisition was performed with Waters Empower™ data software.  Calibration curves fo  
all compounds were constructed by graphing the ratio of peak areas of chemical 
standards to peak areas of the internal standards versus concentration.  Carotenoids in 
serum samples were identified by retention times and quantified using the linear 
regression model using the standard calibration curves.  The inter assay coefficients of 
variation for pooled quality samples were ≤10% for all analytes measured. 
Antioxidant status 
Plasma antioxidant status was determined using a Catalase assay kit (Cman Chemical 
Company, Ann Arbor, MI) according to the manufacturer’s protocols.   Catalase is an 
antioxidant system in humans, primary found in the liver, kidney, and erythrocytes, 
which detoxifies two molecules of hydrogen peroxide by producing one molecule of 
oxygen and two molecules of water [27, 64]. 
Flavonoid Dietary Intakes 
Flavonoid dietary intakes were determined by analyzing each subjects 3-day foo  record 
at baseline and week 8.  Foods containing flavonoids were selected and the amount of 
each flavonoid was quantified using the USDA Flavonoid Database, 2007.  The amounts 
were converted to grams and the mean and standard deviation of these flavonoids were 




Descriptive statistics were calculated for all parameters and graphs drawn to look for 
outliers.  The primary objective was to identify differences in means of inflammation and 
antioxidant parameters at screen (week 0) and end of study (week 8), between the control 
group and the blueberry group.  One-way ANOVA followed by Bonferroni post hoc was 
used to test differences between two groups at screen and end of study (week 8).  Within 
group differences were analyzed using paired t-test.  All data were expressed as means ± 
standard error for the variables of interest, with significance level set at0.05.  SPSS for 








The freeze-dried blueberries were administered as a drink in which 50 grams were 
consumed per day; this is equivalent to eating about 350 grams of fresh blueberries per 
day.  The intervention was well tolerated and compliance to the blueberry drink was high.  
The freeze-dried blueberries had about 174 calories, 86.0 mg of Vitamin C, 1624 mg 
phenolics, and 742 mg anthocyanins per 50 grams (Table 3). 
The 39 subjects included in this study had several of the qualifying criteria for 
metabolic syndrome and these main baseline characteristics (Table 4).  The blueberry 
group had the following characteristics: primarily female, 51.5 ± 3.0 years, BMI of 38.1 
± 1.5, AST of 25.3 ± 1.3 U/L, ALT of 33.1 ± 2.6 U/L, BUN of 12.8 ± 0.7 mg/dL, 22.0% 
were anti-hypertensive medication users, and 12.0% were multivitamin users.  The 
control group had the following characteristics: primarily female, 45.0 ± 3.0 years, BMI 
of 36.4 ± 3.0, AST of 26.7 ± 3.2 U/L, ALT of 34.8 ± 6.9 U/L, BUN of 11.3 ± 1.1 mg/dL, 
24.0% were anti-hypertensive medication users, and 8.0% were multivitamin users.  
There were no significant differences observed at baseline between the two groups.
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Table 5 illustrates the effects of the freeze-dried blueberries on the anthropometrics, 
blood pressure, cholesterol, glucose, and triglyceride levels.  The only significant changes 
observed was a decrease in blood pressure (130.1±3.3/84.0±1.8 to 122.3±2.6/81.2±1.6) 
from baseline to week 8 in the blueberry group.  None of the other parameters measured 
changed in either group from baseline to week 8. 
 Table 6 shows the effects of the freeze-dried blueberries on the biomarkers of 
inflammation, specifically C-reactive protein (CRP), interleukin- 6 (IL-6), and 
adiponectin.  There were no significant changes in any of these biomarkers in either 
group from baseline to week 8. 
 Table 7 shows the serum catalase activity.  Catalase was significantly higher in 
the blueberry group compared to the control group at baseline and week 8.  However, 
there were no significant changes within each group from baseline to week 8.  Table 8 
illustrates the circulating levels of antioxidant carotenoids in the serum, specifically 
alpha-carotene, beta-carotene, lycopene, and lutein.  Lycopene was significantly different 
from baseline to week 8 in the blueberry group (6.87±4.66 to 4.83±2.70 µg/mol).  There 
were no other significant changes in the other carotenoids in either group. 
 The dietary flavonoid intakes are in displayed in Table 9.  The specific flavonoids 
chosen for analysis included kaemperol, myricetin, quercetin, hesperetin, haringenin, 
EGCG, catechin, cyaniding, malvidin, peonidin, and petunidin.  Within the blueberry 
group, hesperetin was the only flavonoid that was significantly higher at week 8 
compared to the baseline intakes.  Within just the control group, catechin was 
significantly lower at week 8 than baseline.  At week 8, the blueberry group had 
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statistically significantly higher levels of quercetin and EGCG compared to the control 




Table 4. Composition of freeze-dried blueberries 
 
  
Nutrients/Antioxidant activity Amount per 
50 grams 
Calories (kcal) 174.0 
Protein (g) 1.7 
Carbohydrates (g) 42.3 
Total Sugars (g) 30.0 
Dietary Fiber (g) 9.3 
Vitamin C (mg) 86.0 
Calcium (mg) 15.0 
Iron (mg) 0.5 
Potassium (mg) 204.0 
Sodium (mg) 8.0 
Phenolics (mg) 1624 
Anthocyanins (mg) 742 
ORAC (µmole TE) 17800 
  
Source: U.S. Highbush Blueberry Council (Folsom, CA) 
Fresh weight replacement: 1 to 7 (freeze-dried to fresh) 
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Table 5. Baseline characteristics of subjects1 
  Blueberry Control 
  (n = 25) (n = 23) 
Age (years) 51.5±3.0 45.0±3.0 
BMI (kg/m 2) 38.1±1.5 36.4±3.0 
M/F   2/23  2/10 
AST (U/L) 25.3±1.3 26.7±3.2 
ALT (U/L) 33.1±2.6 34.8±6.9 
BUN (mg/dL) 12.8±0.7 11.3±1.1 
Creatinine (mg/dL) 0.8±0.1 0.8±0.1 
Albumin (g/dL) 4.1±0.1 3.9±0.1 
Hemoglobin (g/dL) 13.8±0.2 13.5±0.3 
WBC (k/mm3) 7.0±0.4 6.3±0.4 
Anti-hypertensive medication users (%) 22.0 24.0 
Multivitamin users (%) 12.0 8.0 
1Values are means ± SE 




Table 6. Effects of freeze-dried blueberries on anthropometrics, blood pressure and 
clinical variables versus controls1 
Variables Blueberry 
(n = 19) 
Blueberry 
(n = 19) 
Control 
(n = 12) 
Control 
(n = 12) 
  Baseline Week 8 Baseline Week 8 
Body weight (kg) 101.3±4.4 101.0±4.5 103.3±5.4 103.0±5.0 
Waist Circumference (inches) 43.7±1.2 43.6±1.3 43.0±2.0 42.0±1.5 
Systolic blood pressure (mm Hg) 130.1±3.3 122.3±2.6*  131.0±3.2 129.0±3.0 
Diastolic blood pressure (mm Hg) 84.0±1.8 81.2±1.6*  82.0±2.5 81.0±3.0 
Glucose (mmol/L) 5.1±0.2 5.2±0.2 5.1±0.2 5.0±0.2 
HbA1C (%) 5.7±0.1 5.8±0.1 5.8±0.1 6.0±0.1 
HOMA-IR 3.9±0.4 4.6±0.6 3.4±0.4 3.2±0.4 
Triglycerides (mmol/L) 1.7±0.1 1.7±0.2 1.6±0.2 1.7±0.4 
Total cholesterol (mmol/L) 4.9±0.2 5.1±0.2 5.2±0.3 5.4±0.2 
HDL cholesterol (mmol/L) 1.2±0.04 1.2±0.04 1.0±0.05 1.0±0.04 
LDL cholesterol (mmol/L) 3.0±0.15 3.1±0.15 3.8±0.3 3.8±0.2 
1Values are means ± SE 




Table 7. Effects of freeze-dried blueberries on plasma biomarkers of oxidative stress 
and inflammation versus controls1 
Variables Blueberry 
(n = 19) 
Blueberry 
(n = 19) 
Control 
(n = 12) 
Control  
(n = 12) 
  Baseline Week 8 Baseline Week 8 
CRP (mg/L) 5.8±0.6 6.1±0.5 6.9±1.4 7.3±1.5 
IL-6 (pg/mL) 14.6±6.3 14.6±6.2 28.2±13.0 21.0±8.5 
Adiponectin (µ/L) 8.9±0.9 8.9±0.9 7.9±1.5 7.9±1.5 




Table 8. Catalase Activity 
 Blueberry 
(n = 10) 
Blueberry 
(n = 10) 
Control 
(n = 9) 
Control 
(n = 9) 
 Baseline Week 8 Baseline Week 8 
Total 51.332 ± 4.124 52.091± 8.033 32.097 ± 4.332 25.764 ± 4.509 
Values are means ± SE 
*significantly higher than control (p<0.05) at baseline 
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Table 9. Circulating levels of antioxidant carotenoids 
Carotenoids Blueberry Blueberry Control Control 
  (n = 19) (n = 19) (n = 12) (n = 12) 
  0 week 8 week 0 week 8 week 
Alpha-carotene 
(µg/mL) 
0.13±0.05 0.16±0.04 0.15±0.06 0.11±0.02 
Beta-carotene 
(µg/mL) 
0.56±0.32 0.67±0.25 0.54±0.41 0.48±0.42 
Lycopene (µg/mL) 6.87±4.66 4.83±2.70* 5.24±4.76 5.32±4.20 
Lutein (µg/mL) 0.93±0.44 1.12±0.57 1.12±0.8 1.06±0.56 




Table 10. Dietary Flavonoid Intakes1 
Flavonoids Blueberry Blueberry Control Control 
  (n = 19) (n = 19) (n = 12) (n = 12) 
  0 week 8 week 0 week 8 week 
Kaempferol (g) 1.649 ± 0.5985 1.029 ± 0.2848 7.135 ± 5.720 1.186 ± 0.7642 
Myricetin (g) 1.178 ± 0.4013 0.8713 ± 0.3145 0.3531 ± 0.1731 0.2696 ± 0.1670 
Quercetin (g) 15.07 ± 3.761 22.20 ± 6.128*  11.24 ± 2.538 5.768 ± 1.995 
Hesperetin (g) 2.525 ± 1.334 10.39 ± 4.242# 5.284 ± 3.513 4.794 ± 3.183 
Naringenin (g) 2.718 ± 0.9561 5.164 ± 2.303 19.38 ± 18.63 13.78 ± 11.25 
EGCG (g) 4.043 ± 2.592 0.2850 ± 0.0983*  0.1292 ± 0.0634 0.00933 ± 0.00699 
Catechin (g) 8.691 ± 4.232 9.318 ± 4.346 12.50 ± 4.288 4.078 ± 2.496# 
Cyanidin (g) 4.114 ± 1.937 7.014 ± 3.532 6.816 ± 3.079 1.606 ± 0.9090 
Malvidin (g) 11.15 ± 7.372 6.540 ± 4.706 10.26 ± 5.781 0.06816 ± 0.06816 
Peonidin (g) 1.596 ± 1.104 1.119 ± 0.8674 1.358 ± 0.7812 0.07957 ± 0.07707 
Petunidin (g) 2.893 ± 2.226 3.595 ± 2.217 2.454 ± 1.518 0.000 ± 0.000 
Total Intake (g) 55.627 ± 2.410 67.525 ± 2.640 76.909 ± 4.190 31.639 ± 1.901 
1Values are means ± SE 
*significantly different from control (p<0.05) 








 The purpose of this study was to investigate the effects of blueberry flavonoids  
the biomarkers of inflammation and antioxidant status in subjects indentified with 
metabolic syndrome.  We demonstrated that blueberry supplementation caused a 
significant decrease in blood pressure in subjects with metabolic syndrome.  In fact, the 
decrease in systolic blood pressure was 6.0% and 3.3% decrease in diastolic blood 
pressure from baseline to week 8 in the blueberry group; however, there were no 
significant changes in blood pressure in the control group.  None of the other clinical 
parameters changed in either group at the end of the 8 weeks, indicating that the 
blueberry supplementation did have some effect on the blood pressure in the intervention 
group.  The biomarkers of inflammation measured for this study did not change 
significantly in either the blueberry group or control group from baseline to end of the
study.  This indicates that the blueberry supplementation did not have a significant effect 
on these parameters; this could be attributed to the dose or form of the intervention.  The 
catalase activity was measured in both groups and a difference was not seen within each 
group from baseline to week 8.  However, the catalase activity was significantly higher
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in the blueberry group compared to the control group at both baseline and week 8.  This 
indicates that the blueberry drink could potentially have increased the endogenous 
antioxidant capacity.  The dietary flavonoid intakes were also affected with 
supplementation.  For instance, hesperetin was higher at week 8 than baseline within the 
blueberry group (10.39 ± 4.242 g from 2.525 ± 1.334 g, respectively).  In the control 
group, catechin was lower at week 8 compared to baseline with the following levels, 
4.078 ± 2.496 g from 12.50 ± 4.288 g, respectively.  Furthermore, the blueberry group 
had significantly higher levels of quercetin and EGCG at week 8 compared to the control
group (quercetin: 22.20 ± 6.128 g compared to 5.768 ± 1.995 g; EGCG: 0.2850 ± 0.0983 
g compared to 0.00933 ± 0.00699 g).  Since there were no differences at baseline, it is 
likely that the blueberry drink was a large factor in the differences seen at week 8. 
The supplementation was given as 50 grams of freeze-dried blueberry powder 
mixed with four cups of water daily.  This amount is equivalent to 350 grams (or 2 cups) 
of fresh blueberries per day.  It was more reasonable to supplement in this manner due to 
availability of blueberries, cost, and tolerance to the drink.  From the results of our 
current study, it is difficult to come to a definite conclusion at this point in resea ch; 
however, the blueberry supplementation did illustrate a few potential benefits with no 
negative side effects or compliance issues.  Other clinical studies that supplemented 
blueberries have observed similar findings as well in both healthy adults and high risk 
groups.  For example, Kay and Holub observed an increase in serum antioxidant status in 
eight healthy males when supplemented with 100 grams of freeze-dried blueberry powder
after a high-fat diet [59].  Prior et al observed an increased plasma antioxidant capacity 
postprandially in healthy women after consuming 1.12 g/kg body weight freeze-dri d 
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blueberry powder for 14 days [65].  Two studies observed similar effects in subject 
groups that smoked; Van den Berg t al observed an increase in Vitamin C, carotenoids, 
and plasma antioxidant capacity after consuming 330 mL of a fruit juice with 30% 
blueberry juice for 3 weeks [33].  McAnulty et al supplemented 20 smokers with 250 
grams of blueberries daily for 3 weeks and noticed decreased levels of lipid 
hydroperoxides [58].  According to the USDA Food Guide Pyramid and the Dietary 
Guidelines for Americans 2010, the daily recommended fruit intake is 2 cups of fresh 
fruit for adults [66].  Therefore, at this point, it would be safe to recommend moderate 
blueberry consumption of a couple servings a few times a week due to these protective 
qualities.  However, further research is imperative to determine more of these protective 
benefits of blueberries in this specific population of metabolic syndrome and how it 
affects these parameters. 
Inflammation, as seen in obesity and metabolic syndrome, is a response to these 
unnatural conditions.  C-reactive protein (CRP), interleukin-6 (IL-6), and adiponectin are 
just a few of the biomarkers of inflammation monitored in adults.  CRP is an acute phase 
protein produced in the liver and is typically secreted in response to IL-6 production 
induced by trauma, sepsis, infection, or other inflammatory processes.  Research has 
shown it to be a highly reliable predictor of cardiovascular events and is associated w th 
increased triglyceride levels, hypertension, elevated fasting glucose, and obesity [10, 14, 
20, 21, 67].  Sesso et al observed that strawberry intake may have reduced CRP levels in 
participants in the Women’s Health Study [68].  IL-6 is a pro-inflammatory cytokine 
produced in the adipose tissue and is associated with obesity, diabetes, and cardiovascular 
disease.  It is also highly active in lipid metabolism and when IL-6 levels are high, it 
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alters lipid metabolism, further promoting obesity by increasing circulation of free fatty 
acids, triglycerides, and decreasing HDL level [10, 12, 13].  Adiponectin is an anti-
inflammatory adipocytokine produced by the adipose tissue and is regulated by IL-6; 
high levels of IL-6 inhibit adiponectin and these low levels are associated with higher r sk 
and incidence of metabolic syndrome.  Furthermore, adiponectin levels are generally 
decreased in dyslipidemia, diabetes, and cardiovascular disease [12, 22, 69].  The current 
study supplementation showed no significant change in any of these biomarker levels, 
indicating that the dose may not have been high enough or the levels were too high to 
make that much of an impact with the dose given in this study. 
Antioxidants are molecules that scavenge and prevent the accumulation of against 
free radicals which are responsible for the oxidative stress and damage in many disease 
states.  The antioxidant defense systems of interest in this study included the carotenoids 
and catalase.  Clinical studies have shown that consumption of fruit juice rich in 
anthocyanins and polyphenols decreased DNA oxidative damage, lipid peroxidation, and 
oxidative damage while glutathione and endogenous antioxidant status significantly 
increased [25].  Several studies showed that intervention with the carotenoids, 
specifically α-carotene, β-carotene, lutein, and lycopene, help guard against damaging 
oxidation in cells, reduce the risk of hypertension, improve impaired glucose tolerance 
and type 2 diabetes, and overall, lower the risk of developing metabolic syndrome [28, 
30, 31].  The current study did have a significant decrease in lycopene levels in the 
blueberry group, which could be attributed to the group consuming fewer fruits and 
vegetables due to the intervention group assigned to.  This group knew they were 
consuming the blueberry drink and with this knowledge, individuals may have consumed 
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less antioxidant rich foods, despite being advised to keep the diet consistent from baseline 
to week 8.  However, there were no other significant changes in the other carotenoid 
levels in either group.  There were no significant changes in the catalase activity in either 
group, indicating that this dose may have not affected this enzyme. 
 The flavonoids are abundant in fruits and vegetables and dietary intake is 
dependent on how many of these items are consumed daily.  From this study, dietary 
flavonoid intakes, in general, did not significantly change with a few exceptions of 
hesperetin in the blueberry group and catechin in the control group.  There have been a 
few studies that investigated dietary flavonoid intakes in general and in relation to a 
specific disease state.  For instance, Zhang et al investigated the dietary flavonoid 
intakes, specifically flavonols and flavones, in healthy Chinese adults.  The researchers 
observed that the total consumption of these two flavonoids was 19.13 mg/day, with 
quercetin and kaempferol being consumed most frequently [70].  Mennen t al observed 
that French women consuming flavonoid-rich foods had a lower risk of developing 
cardiovascular disease compared to individuals who did not consume food rich in 
flavonoids [71].  Cassidy et al observed during a 14 year population-based study, 
consumption of flavonoids, specifically anthocyanins, flavones, and flavan-3-ols, 
decreased the prevalence of hypertension in men and women [72].  These findings 
indicate that flavonoids obtained through the diet have a potential at lowering risk of 
development of chronic disease. 
 Our study had a few limitations that would need to be considered when designing 
further studies.  For instance, it was a short study duration being only eight weeks long.  
It may be more beneficial if the duration was longer to collect more blood draws and 
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dietary records for compliance, consistency, and more data for statistical analysis.  
Furthermore, the sample size was relatively small, with only 31 subjects.  Thus, samples 
for assays were difficult to obtain and data is limited in this area which made getting 
results complicated.  We only collected one set of dietary food intakes through three-day 
food records for the dietary flavonoid intake.  In the future, it would be wise to collect 
more than one set of dietary intakes and through a more accurate source such as a Food 
Frequency Questionnaire (FFQ) focusing on foods rich in polyphenols, specifically the 
flavonoids, to get a better picture of the dietary flavonoid intakes for this population.  
Regarding clinical parameters, we did not measure serum flavonoid levels due to cost and 
their quick clearance from the body [46, 49].  Research demonstrated that flavonoids, 
specifically anthocyanins, are typically consumed and cleared about six to eigh  hours 
later [46, 49].  Furthermore, we did not collect urine samples due to cost of the procedure.  
In a future study, these may provide more insight to this condition and supplementation. 
In conclusion, the results of the study presented indicated that blueberry 
supplementation in subjects with metabolic syndrome does lower blood pressure and has 
some positive effect on serum carotenoid levels and reinforces the need to further 
understand this condition.  Evidence is emerging that suggests antioxidants may provide 
nutritional benefits to reducing the risk of chronic disease such as cardiovascular disease, 
hypertension, and thus, metabolic syndrome.  The results from this study suggest that 
blueberry supplementation is responsible for lowering blood pressure but it has yet to be 
determined as to how much the blueberry antioxidants affect biomarkers of inflammation 
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Scope and Method of Study: The objective of our study was to investigate the effects o   
blueberry flavonoids on inflammation and antioxidant status in subjects identified 
with Metabolic Syndrome.  Nineteen subjects identified with metabolic syndrome 
were assigned to consume a 50 gram dose of freeze-dried whole blueberry drink 
daily for 8 weeks while 12 subjects were assigned as controls and consumed 
equivalent fluid amounts daily for 8 weeks.  Subjects in both groups kept a 3-day 
food record dietary flavonoid intake for analysis.  Blood draws and 
anthropometrics were performed at baseline and at 8 weeks. 
 
 
Findings and Conclusions: Blueberry supplementation did not significantly alter CRP, 
IL-6, and adiponectin. At week 8, Quercetin and EGCG were significantly higher 
in the blueberry group compared to the control (Blueberry: 22198.48 mg, Control: 
5768.14 mg p=0.047; Blueberry: 284.99 mg, Control: 9.33 mg, p=0.035, 
respectively).  Thus, blueberry supplementation did not alter markers of 
inflammation, and the antioxidant effects may be attributed to the decrease in 
serum carotenoids, specifically lycopene in the blueberry group compared to the 
control at week 8 (6.87±4.66 µg/mL to 4.83±2.70 µg/mL).  In conclusion, the 
results of the study presented indicated that blueberry supplementation in subjects 
with metabolic syndrome does lower blood pressure and has some positive effect 
on serum carotenoid levels and reinforces the need to further understand this 
condition.  Evidence is emerging that suggests antioxidants may provide 
nutritional benefits to reducing the risk of chronic disease such as cardiovascular 
disease, hypertension, and thus, metabolic syndrome.  The results from this study 
suggest that blueberry supplementation is responsible for lowering blood pressure 
but it has yet to be determined as to how much the blueberry antioxidants affect 
biomarkers of inflammation and the other parameters of the metabolic syndrome. 
